RKTO

Hoth Therapeutics, Inc. (NASDAQ:HOTH) is a clinical-stage biopharmaceutical company founded in 2017 and headquartered in New York, New York. The company went public in February 2019 and focuses on developing innovative therapies for unmet medical needs across multiple therapeutic areas. Named after the ice planet from Star Wars, Hoth operates as a development-stage biotechnology company with no current revenue, dedicating its resources to advancing a diverse pipeline of drug candidates through clinical trials and regulatory processes.